Marukome

Marukome is a leading Japanese biotechnology and food science company specializing in the production and research of fermented soybean and rice products. Founded in 1854, the company has transitioned from a traditional miso manufacturer to a modern health-focused enterprise leveraging Aspergillus oryzae (koji) fermentation technology. Marukome's research initiatives focus on the functional benefits of fermentation, including the development of bioactive peptides for blood pressure regulation and the study of koji's impact on the gut microbiome and skin health. The company's product portfolio includes traditional miso, koji-based sweeteners, and functional beverages marketed for their nutritional and probiotic properties. Marukome maintains a strong commitment to scientific validation of traditional Japanese dietary components through collaborations with academic institutions.